Developing treatments to prevent the spread of infectious diseases requires more than a commitment to public health. You need a strong clinical development strategy, supported by an experienced contract research organization, to navigate the complexities of infectious disease clinical trials.

DP Clinical’s extensive infectious disease and vaccine experience enables us to consistently select the best sites, expedite start-up timelines, and meet enrollment targets for our clients. We have worked on Phase I-III studies in various indications with healthy volunteers as well as target patient populations and will help you minimize risk, generate quality data, meet timelines, and maximize efficiencies by proactively navigating the operational complexities of infectious disease trials.

Whether your study is a small, focused trial or a large, global study; DP Clinical has the knowledge and expertise to make sure our study is a success.

DP Clinical’s infectious disease/vaccine experience includes Phase I-III studies in the following indications:

  • Aphthous Stomatitis

  • Anthrax
  • Antibiotics
  • Bacteremia
  • Bacterial Infections
  • Bacterial Pneumonia
  • Bone and Joint Infections
  • Community Acquired Pneumonia
  • COVID-19
  • Cryptosporidiosis
  • Gram-negative infections
  • Gram-positive infections
  • Hansen’s Disease (Leprosy)
  • Hepatitis C

  • Hepatitis C
  • HIV/AIDS
  • Influenza
  • Leprosy
  • Malaria
  • Microsporidiosis
  • Mutans Strep
  • Norovirus
  • Pneumonia
  • Skin and Soft Tissue
  • Staphylococcal Aureus-Neonates
  • Staphylococcal Sepsis-Neonates
  • Staphylococcus
  • Vancomycin-Resistant Enterococci (VRE)
  • Zika Virus